Publications by authors named "Luis F Fabrini Paleare"

Background: The Contour Neurovascular System (CNS, Stryker, Kalamazoo, MI) has a unique design that allows it to address various aneurysm morphologies, including wide-necked, irregular, and shallow-shaped lesions. However, evidence of its safety and efficacy remains limited. This systematic review and meta-analysis synthesizes the current data on CNS performance.

View Article and Find Full Text PDF
Article Synopsis
  • * A total of five randomized controlled trials involving 347 patients were analyzed, showing that those receiving 5-HT3 antagonists had significantly lower rates of vomiting and nausea compared to the placebo group within the first 24 hours post-surgery.
  • * The results support the use of 5-HT3 antagonists in clinical settings to reduce PONV after neurosurgery, with evidence indicating better outcomes compared to placebo treatments.
View Article and Find Full Text PDF

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in older adults and has a poor prognosis and limited response to treatment. The growing impact of palliative care on older people undergoing neurosurgery is becoming increasingly important. Palliative care aims to improve the quality of life for people and their families by addressing their physical, psychosocial, and spiritual needs.

View Article and Find Full Text PDF

Background: Von Hippel-Lindau (VHL) disease is a rare autosomal dominant disorder that predisposes patients to develop multiple cysts and tumors, such as hemangioblastomas (HBs) and clear cell renal cell carcinoma (ccRCC), due to mutations in the VHL tumor suppressor gene. While treatment of HBs varies based on their characteristics and has improved patient survival, it still involves high morbidity and mortality, leading to ongoing debates and studies to refine therapy strategies. Recent developments include the emergence of Belzutifan, a novel inhibitor targeting hypoxia-inducible factor 2α (HIF-2α), which has shown promising results in ongoing trials, particularly for patients not immediately requiring surgery.

View Article and Find Full Text PDF